Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
3,203,885
-
Total 13F shares
-
2,546,020
-
Share change
-
+10,659
-
Total reported value
-
$255,957,647
-
Price per share
-
$100.53
-
Number of holders
-
80
-
Value change
-
+$1,190,438
-
Number of buys
-
39
-
Number of sells
-
23
Institutional Holders of UTAH MEDICAL PRODUCTS INC - Common Shares (UTMD) as of Q4 2022
As of 31 Dec 2022,
UTAH MEDICAL PRODUCTS INC - Common Shares (UTMD) was held by
80 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,546,020 shares.
The largest 10 holders included
FMR LLC, T. Rowe Price Investment Management, Inc., RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, RICE HALL JAMES & ASSOCIATES, LLC, HealthInvest Partners AB, JPMORGAN CHASE & CO, and Ranger Investment Management, L.P..
This page lists
81
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.